CVRx Lands $12,000,000 Series F Funding

  • Feed Type
  • Date
    10/31/2013
  • Company Name
    CVRx
  • Mailing Address
    9201 West Broadway Avenue Minneapolis, MN 55445
  • Company Description
    The company has developed proprietary technology for the treatment of high blood pressure, also referred to as hypertension, that cannot be controlled with medications (refractory or resistant hypertension).
  • Website
    http://www.cvrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series F
  • Proceeds Purposes
    CVRx plans to use the funding for the primary purposes of advancing its clinical trials and expanding its international commercial activities.
  • M&A Terms
  • Venture Investor
    Ysios Capital
  • Venture Investor
    DaVita HealthCare Partners

By posting a comment, you agree to our terms and conditions.